跳至主要内容
临床试验/JPRN-UMIN000040876
JPRN-UMIN000040876招募中未知

A multi-institutional, prospective, observational study of a combination of atezolizumab and chemotherapy for patients with large cell neuroendocrine carcinoma (LCNEC) of the lung (NEJ044) - Atezolizumab and chemotherapy for LCNEC (NEJ044)

orth East Japan Study Group (NEJSG)0 个研究点目标入组 100 人开始时间: 2020年6月24日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Subjects who could not give their consent. 2. Subjects with illnesses or conditions that interfere with their capacity to understand, follow and/or comply with study procedures.

研究者

发起方
orth East Japan Study Group (NEJSG)

相似试验